CDO1 Promoter Methylation is a Biomarker for Outcome Prediction of Anthracycline Treated, Estrogen Receptor-Positive, Lymph Node-Positive Breast Cancer Patients

by Eppenberger-Castori Serenella, Schmitt Manfred, Harbeck Nadia, Lewin Jörn, Fassbender Anne, Dietrich Jörn, Krispin Manuel, Dietrich Dimo, Vuaroqueaux Vincent, Spyratos Frédérique, Foekens John A, Lesche Ralf, Martens John WM
Published 2010-06-01

SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates

by Liloglou Triantafillos, Wille Ulrike, Weickmann Sabine, Tetzner Reimo, Distler Jürgen, Lewin Jörn, Seemann Stefanie, Flemming Nadja, Seegebarth Anke, Schlegel Thomas, Kneip Christoph, Dietrich Dimo, Liebenberg Volker, Schmidt Bernd, Raji Olaide, Walshaw Martin, Fleischhacker Michael, Witt Christian, Field John K
Published 2010-11-01